Intended for healthcare professionals

Letters Orphan drugs

Dutch situation is similar

BMJ 2010; 341 doi: (Published 07 December 2010) Cite this as: BMJ 2010;341:c7018
  1. Marcel Bouvy, professor of pharmaceutical care1
  1. 1Utrecht University, Utrecht, Netherlands
  1. m.l.bouvy{at}

I fully agree with the authors’ analysis.1 The situation in the Netherlands is the same. As a further example to those given by Ferner and Hughes, zinc sulfate …

View Full Text

Log in

Log in through your institution


* For online subscription